A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma

Br J Haematol. 2018 Jan;180(2):176. doi: 10.1111/bjh.14959. Epub 2017 Oct 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Biopsy
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use
  • Humans
  • Immunoblastic Lymphadenopathy / diagnostic imaging
  • Immunoblastic Lymphadenopathy / pathology*
  • Immunophenotyping
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology
  • Lymphoma, T-Cell / diagnosis*
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / etiology
  • Male
  • Neoplasm Regression, Spontaneous*
  • Prednisone / adverse effects
  • Prednisone / therapeutic use
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Vincristine / adverse effects
  • Vincristine / therapeutic use

Substances

  • Biomarkers
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol